Hjerte-karsygdomme og kosttilskud – videnskabelig forskning

1. Anderson TW et al. A double-blind trial of vitamin E in angina pectoris. Am J Clin Nutr 27:1174-8, 1974.

2. Azen SP, Qian D, Mack W, et al. Effect of supplementary antioxidant vitamin intake on carotid arterial wall intima-media thickness in a controlled clinical trial of cholesterol lowering. Circulation 94;10:2369-72, 1996.

3. Barboriak JJ et al. Vitamin E supplements and plasma high-density lipoprotein cholesterol. Letter. Am J Clin Pathol 77;3:371, 1982.

4. Bellizzi MC, Franklin MF, Duthie GG, et al. Vitamin E and coronary heart disease: the European paradox. Eur J Clin Nutr 48:822-31, 1994.

5. Bierenbaum M, Reichstein R, Bhagavan H, et al. Relationship between serum lipid peroxidation products in hypercholesterolemic subjects and vitamin E status. Biochem Int 28:57-66, 1992.

6. Boers GH. Hyperhomocysteinaemia: a newly recognized risk factor for vascular disease. Neth J Med 45:1:34-41, 1994.

7. Boniton-Kopp C, Coudray C, Berr C, et al. Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59-71 y: The Eva study.Am J Clin Nutr 65:121-7, 1997.

8. Bordia A et al. Effect of vitamin C on platelet adhesiveness and platelet aggregation in coronary artery disease patients. Clin Cardiol 810:552-4, 1985.

9. Brattström L et al. Impaired homocysteine metabolism in early-onset cerebral and peripheral occlusive arterial disease. Effects of pyridoxine and folic acid treatment. Atherosclerosis 81:1:51-60, 1990.

10. Brattström L, Stavenow L, Galvard H, et al. Pyridoxine reduces cholesterol and low-density-lipoprotein and increases antithrombin III activity in 80- year-old men with low plasma pyridoxal 5-phosphate. Scand J Clin Lab Invest 50:8:873-7, 1990.

11. Brattström L. Vitamins as homocysteine-lowering agents: a mini review. Presentation at the American Institute of Nutrition Colloquium, April 13, 1995, Atlanta, Georgia; Brattström L. Vitamins as homocysteine-lowering agents. J Nutr 126:4 Suppl:1276S-1280S, 1996.

12. Calzada C, Bruckdorfer K, Rice-Evans C. The influence of antioxidant nutrients on platelet function in healthy volunteers. Atherosclerosis 128;1:97-105, 1997.

13. Campos AM, Lissi EA, Total antioxidant potential of Chilean wines. Nutr Res 16:385-9, 1996.

14. Carpenter KLH, Cheeseman KH, Van Der Veen C, et al. Depletion of alpha-tocopherol in human atherosclerotic lesions. Free Rad Res 23:549- 58, 1995.

15. Cavarocchi NC et al. Superoxide generation during cardiopulmonary bypass: Is there a role for vitamin E? J Surg Res 40:519-27, 1986.

16. Chakrabarty S, Nandi A, Mukhopadhyay C, et al. Protective role of ascorbic acid against lipid peroxidation and myocardial injury. Mol Cell Biochem 111:41-7, 1992.

17. Chamiec T et al. Effects of antioxidant vitamins C and E on signal-averaged electro-cardiogram and acute myocardial infarction. Am J Cardiol 77:237-41, 1996.

18. Choi ESK et al. Correlation of plasma ascorbic acid with cardiovascular risk factors. Am J Clin Nutr 51:511, 1990.

19. Cloarec MJ et al. Alpha-tocopherol: Effect on plasma lipoproteins in hypercholesterolemic patients. Isr J Med Sci 23;8:869-72, 1987.

20. Coghlan JG, Flitter WD, Clutton SM, et al. Lipid peroxidation and changes in vitamin E levels during coronary artery bypass grafting. J Thorac Cardiovasc Surg 106;2:268-74, 1993.

21. Creter D et al. Effect of vitamin E on platelet aggregation in diabetic retinopathy. Acta Hematol 62:74, 1979.

22. Dalery K et al. Homocysteine and coronary artery disease in French Canadian subjects: relation with vitamins B12, B6, pyridoxal phosphate and folate. Am J Cardiol 75:1107-11, 1995.

23. Dallal GE et al. Ascorbic acid, HDL cholesterol, and apolipoprotein A-I in an elderly Chinese population in Boston. J Am Coll Nutr 8;1:69-74, 1989.

24. De Lorgeril , Boissonnat P, Salen P, et al. The beneficial effect of dietary antioxidant supplementation on platelet aggregation and cyclosporine treatment in heart transplant recipients. Transplantation 58:193-4, 1994.

25. DeMaio SJ et al. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty PTCA. J Am Coll Nutr 11;1:68-73, 1992.

26. Dieber-Rotheneder M et al. Effect of oral supplementation with D-alpha-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res 32:1325- 32, 1991.

27. Dobson HM et al. The effect of ascorbic acid on the seasonal variations in serum cholesterol levels. Scot Med J 293:176-82, 1984.

28. Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 3:3:194-202, 1992.

29. Eriksson J, Kohvakka A. Magnesium and ascorbic acid supplementation in diabetes mellitus. Ann Nutr Metab 394:217-23, 1995.

30. Esk C et al. Correlation of plasma ascorbic acid with cardiovascular risk factors. Clin Res 38:A747, 1990.

31. Ferreira R et al. Antioxidant action of vitamins A and E in patients submitted to coronary bypass surgery. Vasc Surg 25:191-5, 1991.

32. Gartside PS, Glueck CJ. Relationship of dietary intake to hospital admission for coronary heart and vascular disease: The NHANES II National Probability Study. J Am Coll Nutr 12:6:5676-84, 1993.

33. Gatto LM, Hallen GK, Brown AJ, Samman S. Ascorbic acid induces a favorable lipoprotein profile in women. J Am Coll Nutr 152:154-8, 1996.

34. Gey KF et al. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 53:326S-34S, 1991.

35. Gey KF, Stahelin HB, Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective Study. Clin Invest 71:3-6, 1993.

36. Ginter E et al. Vitamin C in the control of hypercholesterolemia in man. Int J Vitam Nutr Res Suppl 23:137-52, 1982; Turley S et al. Role of ascorbic acid in the regulation of cholesterol metabolism and the pathogenesis of atherosclerosis. Atherosclerosis 24:1-18, 1976.

37. Ghosh S, et al. Dietary intake and plasma levels of antioxidant vitamins in health and disease: a hospital-based case-control study. J Nutr Environ Med 5:235-42, 1995.

38. Gribauskas P et al. [Manganese levels in hair as an additional indicator for early diagnosis of ischemic disease of the heart.] Lab Delo ;10:629, 1985.

39. Hallfrisch J et al. High plasma vitamin C associated with increased plasma HDL- and HDL 2 -cholesterol. Clin Res 39:A203, 1991.

40. Hallfrisch J, Singh VN, Muller DC, et al. High plasma vitamin C associated with high plasma HDL-and HDL2 cholesterol. Am J Clin Nutr 60:100-5, 1994.

41. Hennig B et al. Protective effects of vitamin E in age-related endothelial cell injury. Int J Vitam Nutr Res 59:273-9, 1989.

42. Hennig B. Mechanisms of atherosclerosis: Nutrition and endothelial cell integrity. Abstract. J Am Coll Nutr 12:594, 1993.

43. Herbaczynska-Cedro K, Klosiewicz-Wasek B, Cedro K, et al. Supplementation with vitamins C and E suppresses leukocyte oxygen free radical production in patients with myocardial infarction. Eur Heart J 16:1044-9, 1995.

44. Hermann WJ et al. The effect of tocopherol on high-density lipoprotein cholesterol: A clinical observation. Am J Clin Pathol 72:848-52, 1979.

45. Hodis HN, Mack WJ, LaBree L, et al. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 273;23:1849-54, 1995.

46. Horsey J, Livesley B, Dickerson JW. Ischemic heart disease and aged patients: effects of ascorbic acid on lipoproteins. J Hum Nutr 35:1:53-8, 1981.

47. Jacques PF et al. Ascorbic acid, HDL, and total plasma cholesterol in the elderly. J Am Coll Nutr 6;2:169-74, 1987.

48. Jacques PF. Effects of vitamin C on high-density lipoprotein cholesterol and blood pressure. J Am Coll Nutr 11;2:139-44, 1992.

49. Jacques PF, Sulsky SI, Perrone GA, Schaefer EJ. Ascorbic acid and plasma lipids. Epidemiology 5:19-24, 1994.

50. Jacques PF, Sulsky SI, Perrone GE, et al. Effect of vitamin C supplementation on lipoprotein cholesterol, apolipoprotein, and triglyceride concentrations. Ann Epidemiol 51:52-9, 1995.

51. Jain SK, McVie R, Jaramillo JJ, et al. The effect of modest vitamin E supplementation on lipid peroxidation products and other cardiovascular risk factors in diabetic patients. Lipids 31:S87-90, 1996.

52. Jandak J et al. Reduction of platelet adhesiveness by vitamin E supplementation in humans. Thrombosis Res 49:393-404, 1988.

53. Jandak J et al. Alpha tocopherol, an effective inhibitor of platelet adhesion. Blood 73:141-9, 1989.

54. Jenkins David JA et al. Effect of a diet high in vegetables, fruit, and nuts on serum lipids. Metabolism 46:5:530-37, 1997.

55. Jenkens DJ. Optimal diet for reducing the risk of arteriosclerosis. Can J Cardiol 11Suppl G:118G-121G, 1995.

56. Jialal I, Vega Gl, Grundy SM. Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. Atherosclerosis 82:185-91, 1990.

57. Jialal I, Grundy SM. Effect of dietary supplementation with alpha-tocopherol on the oxidative modification of low density lipoprotein. J Lipid Res 33;6:899-906, 1992.

58. Jialal L, Fuller CJ, Hunt BA. The effect of alpha-tocopherol supplementation on LDL oxidation. Arterioscler Thromb Vasc Biol 15:190-8, 1995.

59. Kang SS. Treatment of hyperhomocysteeinemia: physiological basis. J Nutr 126:4 Suppl:1273S-5S, 1996.

60. Key TJA et al. Dietary habits and mortality in 11,000 vegetarians and health conscious people: Results of a 17 year follow up. BMJ 313:775-9, 1996.

61. Khaw K-T, et al. Lancet, Vol. 357; 9257: p. 657-663.

62. Khaw K-T, Woodhouse P. Interrelation of vitamin C, infection, hemostatic factors and cardiovascular disease. BMJ 310:1559-63, 1995.

63. Knekt P, Reunanen A, Jarvinen R, et al. Antioxidant vitamin intake and coronary mortality in an longitudinal population study. Am JEpidemiol 139:1180-9, 1994.

64. Kok FJ et al. Low vitamin B6 status in patients with acute myocardial infarction. Am J Cardiol 63:513-16, 1989.

65. Kok FJ et al. Decreased selenium levels in acute myocardial infarction. JAMA 261;8:1161-4, 1989.

66. Kornecki E, Feinberg H. Mechanism of inhibition of thrombin-induced platelet aggregation by pyridoxal phosphate. Biochem Biophys Res Commun 90:3:963-8, 1979.

67. Korpela H et al. Effect of selenium supplementation after acute myocardial infarction. Res Commun Chem Pathol Pharmacol 65:249-52, 1989.

68. Kritchevsky SB, Shimakawa T, Tell GS, et al. Dietary antioxidants and carotid artery wall thickness: the ARIC study. Circulation 92:8:2142-50, 1995.

69. Kunisaki M, Umeda P, Inoguchi T, et al. Vitamin E binds to specific binding sites and enhances prostacyclin production by cultured aortic endothelial cells. Thromb Haemost 68:744-51, 1992.

70. Kushi KH, olsom AR, Prineas RJ, et al. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 334:1156-62, 1996.

71. Kuzuya F. Arteriosclerosis in pyridoxine deficient-monkeys. Primates 2:99, 1959.

72. Kuzuya F F. Experiment on arteriosclerosis and arteriolosclerosis induced in pyridoxine-deficient monkeys and their recovery. Primates 3:77, 1962.

73. Kuzuya F. Reversibility of arteriosclerosis in pyridoxine-deficient monkeys, in G Schettler, Y Goto, Y Hata, G Klose, Eds. Atherosclerosis IV. Berlin, Springer-Verlag, 1977:275-8.

74. Kuzuya F. Vitamin B6 and arteriosclerosis. Nagoya J Med Sci 55:1-4:1-9, 1993.

75. Lam SC et al. Investigation of possible mechanisms of pyridoxal-5-phosphate inhibition of platelet reactions. Thrombosis Res 20:633-45, 1980.

76. Lefavi R. Lipid-lowering effects of a dietary nicotinic acid-chromium III complex in male athletes. FASEB J 5;6:A1645, 1991.

77. Lefavi R et al. Lipid-lowering effect of a dietary chromium III-nicotinic acid complex in male athletes. Nutr Res 13:239-49, 1993.

78. Levene CI, Murray JC. The aetiological role of maternal B6 deficiency in the development of atherosclerosis. Lancet i:628, 1977.

79. Levine GN, Frei B, Koulouris SN, et al. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation 93:6:1107-13, 1996.

80. Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am J Clin Nutr 64:190-6, 1996.

81. Lynch S, Klevay L. Effects of a dietary copper deficiency on plasma coagulation factor activities in male and female mice. J Nutr Biochem 3:387, 1992.

82. Mancini M et al. Antioxidants in the Mediterranean diet. Can J Cardiol 11Suppl G:105-9, 1995.

83. Manson JE, Stampfer MJ, Willett WC, et al. A prospective study of antioxidant vitamins and incidence of coronary heart disease in women. Abstract. J Am Coll Nutr 11:5:633, 1992.

84. McCully KS, Wilson RB. Homocysteine theory of arteriosclerosis. Atherosclerosis 22:2:215-27, 1975.

85. Meleady RA et al. Genes, greens, and homocysteine. Heart 76:103-4, 1996.

86. Mezzetti A, Lapenna D, Pierdomenico SD, et al. Vitamins E, C and lipid peroxidation in plasma and arterial tissue of smokers and nonsmokers. Atherosclerosis 112:91-9, 1995.

87. Miwa K, Miyagi Y, Igawa A, et al. Vitamin E deficiency in variant angina. Circulation 94;1:14-18, 1996.

88. Moore JA et al. Selenium concentrations in plasma of patients with arteriographically defined coronary atherosclerosis. Clin Chem 30:1171, 1984.

89. Muckle T, Hazir D. Variation in human blood high-density lipoprotein response to oral vitamin E megadosage. Am J Clin Pathol 91:165-71, 1989.

90. Mudd SH et al. The natural history of homocystinuria due to cystathionine beta-synthase deficiency. Am J Hum Genet 37:1:1-31, 1985.

91. Mushett CW, Emerson G. Arteriosclerosis in pyridoxine-deficient monkeys and dogs. Fed Proc 4:526-7, 1956.

92. Ness A, Khaw K, Bingham S, Day NE. Vitamin C status and serum lipids. Eur J Clin Nutr 50; 11:724-9, 1996.

93. Novelli GP et al. Vitamin E protects human skeletal muscle from damage during surgical ischemia-reperfusion. Am J Surg March 173:206-9, 1997.

94. Nyyssonen K et al. Vitamin C deficiency and risk of myocardial infarction: prospective population study of men from Eastern Finland. BMJ 314:634-8, 1997.

95. Ohvall M et al. Gamma, but not alpha tocopherol levels in serum are reduced in coronary heart disease patients. J Int Med 239:111-17, 1996.

96. Olszewski AJ et al. Reduction of plasma lipid and homocysteine levels by pyridoxine, folate, cobalamin, choline, riboflavin, and troxerutin in atherosclerosis. Atherosclerosis 75:1:1-6, 1989.

97. Oster O et al. The serum selenium concentration of patients with acute myocardial infarction. Ann Clin Res 18;1:36-42, 1986.

98. Pories WJ, Henzel JH, Hennessen JA. Proc U of Missouri First Annual Conference on Trace Substances in the Environment and Health, 1967. 1968:114.

99. Porkkala-Sarataho E, Nyyssonen K , Salonen JT. Increased oxidation resistance of atherogenic plasma lipoproteins at high vitamin E levels in non-vitamin e supplemented men. Atherosclerosis 124;1:83-94, 1996.

100. Princen H, van Poppel G, Vogelezang C, et al. Supplementation with vitamin E but not beta carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro: Effect of cigarette smoking. Arter Throm 12:554-62, 1992.

101. Princen HM, van Duyvenvoorde W, Buytenhek R, et al. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler Thromb Vasc Biol 15:325-33, 1995.

102. Ramirez J, Flowers NC. Leukocyte ascorbic acid and its relationship to coronary artery disease in man. Am J Clin Nutr 3:10:2079-87, 1980.

103. Rath M, Pauling L. Solution to the puzzle of human cardiovascular disease: its primary cause is ascorbate deficiency leading to the deposition of lipoprotein a and fibrinogen/fibrin in the vascular wall. J Orthomol Med 6:3-4:125-34, 1991.

104. Rath M, Pauling L. A unified theory of human cardiovascular disease leading the way to the abolition of this disease as a cause for human mortality. J Orthomol Med 7:1:5-15, 1992.

105. Regnström J, Nilsson J, Moldeus P, et al. Inverse relation between the concentration of low-density- lipoprotein vitamin E and severity of coronary artery disease. Am J Clin Nutr 63:377-85, 1996.

106. Renaud S, de Lorgeril M, Delaye J, et al. Cretan Mediterranean dietfor prevention of coronary heart disease. Am J Clin Nutr 61suppl:1360S-7S, 1995.

107. Riemersma RA, Wood DA, MacIntyre CCH, et al. Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene. Lancet 337:1-5, 1991.

108. Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 32820:1450-6, 1993.

109. Rinehart JF, Greenberg LD. Vitamin B6 deficiency in the Rhesus monkey. Am J Clin Nutr 4:318-25, 1956; Rinehart JF, Greenberg LD. Arteriosclerotic lesions in pyridoxine deficient monkeys. Am J Pathol 25:481-96, 1949.

110. Rinehart JF, Greenberg LD. Pathogenesis of experimental arteriosclerosis in pyridoxine deficiency with notes on similarities to human arteriosclerosis. Arch Pathol 51:12-29, 1951.

111. Rhinehart JF, Greenberg LD. Vitamin B6 deficiency in the rhesus monkey, with particular reference to the occurrence of atherosclerosis, dental caries and hepatic cirrhosis. Am J Clin Nutr 4:318, 1956.

112. Sahyoun NR et al. Carotenoids, vitamins C and E, and mortality in an elderly population. Am J Epidemiol 144:5:501-11, 1996.

113. Salonen JT et al. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet ii:175-9, 1982.

114. Salonen JT et al. Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis. Br Med J 302:756-60, 1991.

115. Serfontein WJ, Ubbink JB, De Villiers LS, et al. Plasma pyridoxal-5-phosphate level as risk index for coronary artery disease. Atherosclerosis 55:3:357-61, 1985.

116. Shah DR et al. Effect of oral zinc sulphate on serum lipids and lipoproteins in human subjects. Indian J Physiol Pharmacol 32;1:47-50, 1988.

117. Simon E et al. Plasma and erythrocyte vitamin E content in asymptomatic hypercholesterolemic subjects. Clin Chem 43:2:285-9, 1997.

118. Simons LA, Von Konigsmark M, Balasubramaniam S. What dose of vitamin E is required to reduce susceptibility of LDL to oxidation? Aust N Z J Med 26;4:496-503, 1996.

119. Singh R, Niaz M, Bishnol J, et al. Diet, antioxidant vitamins, oxidative stress, and risk of coronary artery disease. Acta Cardiol 49:5:453-67, 1994.

120. Singh RB, Ghosh S, Niaz MA, et al. Dietary intake, plasma levels of antioxidant vitamins and oxidative stress in relation to coronary artery disease in elderly subjects. Am J Cardiol 76:1233-8, 1995.

121. Singal PK, Dhillon KS, Beamish RE, Dhalla NS. Protective action of zinc against catecholamine-induced myocardial changes. Electrocardiographic and ultrastructural studies. Lab Invest 44:426, 1981.

122. Singal PK, Kapur N, Dhillon KS et al. Role of free radicals in catecholamine induced cardiomyopathy. Can J Physiol Pharmacol 60:1390, 1982.

123. Sklodowska M, Wasowicz W, Gromnadzinska J, et al. Selenium and vitamin E concentrations in plasma and erythrocytes of angina pectoris patients. Trace Elem Med 8:113-17, 1991.

124. Stampfer M, Hennekens C, Manson J, et al. Vitamin E consumption and the risk of coronary heart disease in women. N Engl J Med 328:1444-9, 1993.

125. Stead NW et al. Selenium Se balance in the dependent elderly. Am J Clin Nutr 39:677, 1984.

126. Steiner M. Influence of vitamin E on platelet function in humans. J Am Coll Nutr 10;5:466-73, 1991.

127. Steiner M, Glantz M, Lekos A. Vitamin E plus aspirin compared with aspirin alone in patients with transient ischemic attacks. Am J Clin Nutr 62;suppl:1381S-4S, 1995.

128. Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study CHAOS. Lancet 347:781-6, 1996.

129. Stone WL et al. Effects of dietary selenium and vitamin E on plasma lipoprotein cholesterol levels in male rats. Ann Nutr Metab 30:94-103, 1986.

130. Street DA et al. Serum antioxidants and myocardial infarction: Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction? Circulation 90;3:1154-61, 1994.

131. Suadicani P, Hein H, Gyntelberg F. Serum selenium concentration and risk of ischaemic heart disease in an prospective cohort study of 3000 males. Atherosclerosis 96:33-42, 1992.

132. Subbarao K et al. Pyridoxal 5′-phosphate – a new physiological inhibitor of blood coagulation and platelet function. Biochem Pharmacol 28:531-4, 1979.

133. Suzukawa M, Ishikawa T, Yoshida H, Tokorozawa N. Effect of in-vivo supplementation with low-dose vitamin E on susceptibility of low-density lipoprotein and high-density lipoprotein to oxidative modification. J Am Coll Nutr 14:1:46-52, 1995.

134. Takamatsu S, Takamatsu M, Satoh K, et al. Effects on health of dietary supplementation with 100 mg d-alpha tocopheryl acetate, daily for 6 years. J Int Med Res 23:342-57, 1995.

135. Tomoda H, Yoshitake M, Morimoto K, Aoki N, et al. Possible prevention of postangioplasty restenosis by ascorbic acid. Am J Cardiology 78;11:1284-6, 1996.

136. Toohey L et al. Plasma ascorbic acid concentrations are related to cardiovascular risk factors in African-Americans. J Nutr 126:121-8, 1996.

137. Torun M et al. Serum levels of vitamin E in relation to cardiovascular diseases. J Clin Pharm Therap 20:335-40, 1995.

138. Ubbink JB, Vermaak WJH, van der Merwe A, Becker PJ. Vitamin B-12, vitamin B-6, and folate nutritional status in men with hyperhomocysteinemia. Am J Clin Nutr 57:47-53, 1993.

139. Urberg M et al. Hypocholesterolemic effect of nicotinic acid and chromium supplementation. J Fam Pract 27;6:603-6, 1988.

140. Vallance BD, Hume R, Weyers E. Reassessment of changes in leucocyte and serum ascorbic acid after acute myocardial infarction. Br Heart J 40;1:64-8, 1978.

141. Verhoef P, Stampfer MJ, Buring JE, et al. Homocysteine metabolism and risk of myocardial infarction: relation with vitamin B6, B12, and folate. Am J Epidemiol 143:9:845-59, 1996.

142. Verlangieri AJ, Bush MJ. Effects of d-a-tocopherol supplementation on experimentally induced primate atherosclerosis. J Am Coll Nutr 11;2:131-8, 1992.

143. Vermaak WJH et al. Vitamin B6 and coronary heart disease. Epidemiological observations and case studies. Atherosclerosis 63:235, 1987.

144. Vijaya I et al. Trace metal analysis in the aorta with and without atherosclerotic lesions. Trace Elem Electrolytes 12;4:200-2, 1995.

145. Vijayammal PL, Kurup PA. Pyridoxine and atherosclerosis: Role of pyridoxine in the metabolism of lipids and glycosaminoglycans in rats fed normal and high fat, high cholesterol diets containing 16% casein. Austral J Biol Sci 31:1:7-20, 1978.

146. Virtamo J et al. Serum selenium and the risk of coronary heart disease and stroke. Am J Epidemiol 122:276-82, 1985.

147. Willis GC, Light AW, Gow WS. Serial arteriography in atherosclerosis. Can Med Assoc J 71:562-8, 1954.

148. Willis GC, Fishman S. Ascorbic acid content of human arterial tissue. Can Med Assoc J 72:500-3, 1955.

149. Woodside J et al. the effects of vitamin supplementation on cardiovascular risk. J Inherit Metabol Dis 19:Suppl 1:26/P51, 1996.

150. Yau TM, Weisel RD, Mickle DA, et al. Vitamin E for coronary bypass operations. A prospective, double-blind, randomized trial. J Thorac Cardiovasc Surg 108;2:302-10, 1994.